A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance
Byeong-Yun AHN; Chang-Kyung KANG; Jong-Do SEO; Pyoeng-Gyun CHOE; Sang-Hoon SONG; Wan-Beom PARK; Sang-Won PARK; Nam-Joong KIM; Myoung-don OH.
Journal of Korean Medical Science
; : e231-2020.
Artículo
| WPRIM | ID: wpr-831636
There have been controversies on the prophylactic effect of hydroxychloroquine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We describe a patient, 60-year old Korean woman, with coronavirus disease 2019 (COVID-19) who had been taking hydroxychloroquine for 6 months. Her serum and saliva concentrations of hydroxychloroquine were 280 μg/L and 4,890 μg/L, respectively. The present case raises concerns on hydroxychloroquine's role as a prophylactic agent for COVID-19.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados